10/20/2023
KardioStatus, a Brown-based biotechnology software development company, uses biometric data and AI to predict individual patient outcomes.
Transforming Biometric Data into Clinically Actionable Therapeutics
225 Dyer Street
Providence, RI
02903
Be the first to know and let us send you an email when KardioStatus posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to KardioStatus: